tiprankstipranks
Trending News
More News >
Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX
US Market

Eupraxia Pharmaceuticals (EPRX) Cash flow

Compare
30 Followers

Eupraxia Pharmaceuticals Cash Flow

EPRX's free cash flow for Q4 2025 was C$-13.85M. For the 2025 fiscal year, EPRX's free cash flow was decreased by C$-10.62M and operating cash flow was C$-13.58M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Mar 24Dec 22Dec 21
Operating Cash Flow
C$ -39.90MC$ -29.99MC$ -27.92MC$ -18.78MC$ -14.64M
Investing Cash Flow
C$ -822.93KC$ -75.16KC$ -99.03KC$ 8.70MC$ -14.45M
Financing Cash Flow
C$ 106.28MC$ 45.78MC$ 27.84MC$ 13.52MC$ 49.92M
End Cash Position
C$ 110.43MC$ 33.10MC$ 19.34MC$ 24.74MC$ 20.89M
Free Cash Flow
C$ -40.72MC$ -30.10MC$ -28.02MC$ -19.08MC$ -15.07M
Currency in CAD

Eupraxia Pharmaceuticals Cash Flow